Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Health claims

Health claims

Functional foods and supplements are as successful as the claims they can make. But new health claim regulations in Europe, and a tightening regulatory environment in the US can make it hard to know how messages must be communicated without overstepping the line.

German courts pre-empting EC joint health claims

Glucosamine and chondroitin products are being stripped from shelves in Germany following local court orders based on European Food Safety Authority (EFSA) negative health claim opinions – before they have...

EFSA gut health workshop will decide Danone’s next claims move

Global probiotics leader Danone says its withdrawn probiotic health claim dossiers will remain untouched on its shelves at least until it attends a gut and immune health claim workshop to...

EFSA health claims summit

“Dialogue is key” says EFSA, but industry not satisfied

The European Food Safety Authority yesterday committed to increased applicant dialogue and a series of health claim workshops at the stakeholders meeting it hosted yesterday at its Parma headquarters, but...

Do food claims improve consumer health, asks BNF

Functional and fortified foods have a key role to play in filling the nutritional gaps in consumer diets, but on-pack signposting is key to helping people make informed choices, says...

EFSA health claims summit

Industry hoping for answers at EFSA health claims summit

About 250 highly concerned industry representatives have gathered at EFSA’s Parma headquarters today for a day-long health claims summit, with early reports this morning indicating there was little being...

EFSA health claim opinion

EFSA turns down beta-glucan immunity health claim

The latest negative health claim opinion from the European Food Safety Authority (EFSA) finds no immune benefits linked to a yeast extract supplied by German firm Leiber.

Health claims will change – not stifle – innovation, NDA panel member

The EU Nutrition and Health Claims Regulation is unlikely to stifle innovation within the food industry as many fear, according to a member of the European Food Safety Authority’s NDA...

Dairy industry gives Codex meeting a mixed review

A recent Codex meeting considering proposals on labelling additives and nutrients has received a mixed reception from dairy trade representatives.

IPA president outlines probiotic challenges

Scott Bush, the VP of marketing, health and nutrition in Bioactives at Danisco USA, talks to Stephen Daniells about the challenges the probiotics industry faces in the form of new...

EFSA health claim opinion

EFSA rejects Innéov skin health claim

French nutricosmetics specialist Laboratoires Innéov has had a submission linking its proprietary blend with improved skin health turned down by the European Food Safety Authority (EFSA) health claims panel.

EFSA panel admits errors in health claim opinion

The European Food Safety Authority (EFSA) has admitted that it made mistakes in the initial judgement of Gencor Pacific’s health claims dossiers, NutraIngredients can exclusively reveal.

EFSA health claims approach ‘medicalises’ foods, says industry

The European Food Safety Authority’s (EFSA) approach to assessing health claims is resulting in the ‘medicalisation’ of food and is blocking scientifically-backed health communication, according to food and supplement industry...

Health claim creativity called for at Vitafoods

With little change in sight in the European Union’s new stringent health claims system, industry is being urged to get creative to promote healthy foods and supplements, at a packed...

Workshop breaks down EU supplement rules

European food supplements manufacturers will be gathering in Brussels next month to navigate the European legislative framework for their products, with the aim of breaking down the key steps to...

Comment

IOM report: One step forward, two steps back

The call for better biomarkers to substantiate health claims is a bold and timely move, but we need to move away from trying to judge foods as pharmaceuticals.

Brown algae extract seeks weight management health claim

French start-up Algues et Mer has lodged an article 13.5 proprietary and emerging science weight management health claim for a brown algae extract under the European Union nutrition and health...

EFSA health claim opinion

EFSA says no to Gencor weight loss claims

An ethanol-water extract of Caralluma fimbriata is not sufficiently substantiated to carry weight loss health claims, according to new opinions issued by the European Food Safety Authority.

Industry needs time to adjust to ‘morphing’ European regulations

The European health claims regulations are morphing and industry and the panel members need time to adjust, says a leading industry figure.

Vitafoods 2010

Vitafoods investigates health claims

As the drama surrounding the European Union health claims system thickens, Vitafoods hosts a day-long seminar that will unpick key issues from marketing practices to the drug/food borderline to legal...

Probi handed six months to alter probiotic messaging

Swedish probiotics supplier Probi has six months to cease linking its probiotic strain Lactobacillus plantarum 299v with improved iron absorption, after its health claim rejection was written into the Official...

Send questions to health claims discussion

A health claims discussion forum to be held on the last day of the VitaFoods trade show in Geneva is inviting questions from potential attendees.

Exclusive interview

Spend on science not marketing for a positive health claim: EFSA scientist

Companies should put more money into studies to substantiate the science of probiotics, perhaps at the cost of marketing, a member of EFSA’s evaluating panel has said.

Probiotic juice buoyant amid claim rejections

Sales of the world’s first probiotic juice, ProViva, have not been dented by the raft of probiotic strain negative opinions flowing from the European Food Safety Authority (EFSA), with sales...

Provexis not concerned about reduced DSM stake

DSM Ventures decision to sell 33m shares and reduce its stake in UK biotech start-up Provexis from 20.8 to 17.8 per cent, represents profit-making rather than any kind of fire...

Special edition: joint health

Regulation: Joint sales not hurt by health claim hole

The joint health space is in good shape in most markets globally with (mostly supplement) sales sitting at about $2bn.

Key Industry Events